Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment

Ann Allergy Asthma Immunol. 2018 May;120(5):537-538.e1. doi: 10.1016/j.anai.2017.12.023. Epub 2018 Mar 19.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bacterial Infections / diagnosis
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / genetics
  • Bacterial Infections / immunology
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 4
  • Exanthema / chemically induced
  • Exanthema / drug therapy*
  • Exanthema / genetics
  • Exanthema / immunology
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Deficiency Syndromes / diagnosis
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology
  • Infant, Newborn
  • Methotrexate / adverse effects
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / genetics
  • Opportunistic Infections / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Remission Induction
  • Translocation, Genetic
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous
  • Methotrexate